Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli
- PMID: 7019087
- PMCID: PMC351564
- DOI: 10.1128/iai.32.3.1100-1104.1981
Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli
Abstract
Rats immunized with Escherichia coli heat-labile (LT) enterotoxin, either in the form of the holotoxin derived from a transformed K-12 strain or the polymyxin-release form obtained from human strains which produce LT toxin alone (LT+/ST- [ST is heat-stable toxin)] or together with ST toxin (LT+/ST+), were challenged with viable organisms of 10 different serotypes, 5 LT+/ST- and 5 LT+/ST+. The serum antitoxin response was monitored by enzyme-linked immunosorbent assay, and the degree of protection was determined by challenge in ligated ileal loops. Immunization with the holotoxin provided a strong antitoxin response and protection against all 10 challenge strains. Immunization with toxin from the LT+/ST+ strain provided equally strong protection against all strains, but immunization with toxin from the LT+/ST- strain yielded only a weak antitoxin response, moderate protection against challenge with LT+/ST- strains, and no protection against LT+/ST- strains, increasing by fivefold the immunization dosage of the LT+/ST- toxin failed to enhance protection. These observations (i) establish the fact that immunization with the LT holotoxin provides uniformly strong protection against heterologous serotypes and (ii) indicate that, for reasons which remain to be determined, the immunogenicity of the polymyxin-release LT from an LT+/ST+ strain differs from that of an LT+/ST- strain.
Similar articles
-
Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin.Infect Immun. 1981 Jan;31(1):144-50. doi: 10.1128/iai.31.1.144-150.1981. Infect Immun. 1981. PMID: 7011990 Free PMC article.
-
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.Infect Immun. 1984 Mar;43(3):811-6. doi: 10.1128/iai.43.3.811-816.1984. Infect Immun. 1984. PMID: 6365784 Free PMC article.
-
Protection in rats immunized with Escherichia coli heat-stable enterotoxin.Infect Immun. 1981 Nov;34(2):637-9. doi: 10.1128/iai.34.2.637-639.1981. Infect Immun. 1981. PMID: 7030964 Free PMC article.
-
Adhesion of enterotoxigenic Escherichia coli in humans and animals.Ciba Found Symp. 1981;80:142-60. doi: 10.1002/9780470720639.ch10. Ciba Found Symp. 1981. PMID: 6114818 Review.
-
Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin.Hum Vaccin Immunother. 2019;15(6):1379-1388. doi: 10.1080/21645515.2018.1496768. Epub 2018 Aug 21. Hum Vaccin Immunother. 2019. PMID: 30081709 Free PMC article. Review.
Cited by
-
Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas.Infect Immun. 1984 Nov;46(2):564-9. doi: 10.1128/iai.46.2.564-569.1984. Infect Immun. 1984. PMID: 6389350 Free PMC article.
-
Immunity to heat-labile enterotoxins of porcine and human Escherichia coli strains achieved with synthetic cholera toxin peptides.Infect Immun. 1986 May;52(2):562-7. doi: 10.1128/iai.52.2.562-567.1986. Infect Immun. 1986. PMID: 3009330 Free PMC article.
-
Immunological and physicochemical characterization of heat-labile enterotoxins isolated from two strains of Escherichia coli.Infect Immun. 1982 Nov;38(2):806-9. doi: 10.1128/iai.38.2.806-809.1982. Infect Immun. 1982. PMID: 6183221 Free PMC article.
-
Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin.Infect Immun. 1984 May;44(2):268-73. doi: 10.1128/iai.44.2.268-273.1984. Infect Immun. 1984. PMID: 6425218 Free PMC article.
-
Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.Infect Immun. 2007 May;75(5):2163-70. doi: 10.1128/IAI.01740-06. Epub 2007 Jan 29. Infect Immun. 2007. PMID: 17261601 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical